Enrolling by invitationNot applicableNCT05398250

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

Studying PLA2G6-associated neurodegeneration

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of North Carolina, Chapel Hill
Principal Investigator
Danielle Roubinov, PhD
University of North Carolina, Chapel Hill
Intervention
Safety Planning Intervention tailored for Autistic Individuals(behavioral)
Enrollment
1665 target
Eligibility
12-99 years · All sexes
Timeline
20222027

Study locations (5)

Collaborators

Patient-Centered Outcomes Research Institute · University of Pennsylvania · Nationwide Children's Hospital · Hugo W. Moser Research Institute at Kennedy Krieger, Inc. · Children's Hospital of Philadelphia · Seattle Children's Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05398250 on ClinicalTrials.gov

Other trials for PLA2G6-associated neurodegeneration

Additional recruiting or active studies for the same condition.

See all trials for PLA2G6-associated neurodegeneration

← Back to all trials